Tag: Vici

Michael Lichtenberg

Mid-term follow-up data for venous stent confirms high patency in line...

Clinical outcomes with the Vici venous stent system (Boston Scientific) have been described as “very good”, according to a presentation of 24- and 36-month...

VIRTUS subanalysis identifies correlates to improved patient outcomes after venous stenting

 Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of...

Veniti announces Boston Scientific distribution agreement for Vici venous stent

Boston Scientific will distribute Veniti’s Vici venous stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries...